The undersigned 67 public health, HIV, hepatitis, and STD community-based organizations, along with providers, community health centers, and advocacy organizations are writing to urge you to change a Centers for Disease Control and Prevention (CDC) policy that can immediately help increase access to pre-exposure prophylaxis (PrEP) for the prevention of HIV. We ask the CDC to reverse its current prohibition and allow recipients of all HIV prevention funds to pay for PrEP ancillary services such as laboratory services for PrEP screening and monitoring.
Letter on FY2022 HIV prevention funding for PrEP in community health centers
We urge Congress to capitalize on the expertise of the community health centers as part of the EHE initiative so that we can expand PrEP and PrEP-related services by increasing funding from the current $102 million to $152 million, as proposed by President Biden’s FY2022 budget.
Letter to Tamara Jensen on Medicare NCD Update for Hepatitis C Screening
The HIV+Hepatitis Policy Institute and others are requesting that CMS update the HCV screening National Coverage Determination to bring it in line with the 2020 U.S. Preventive Services Task Force recommendation for HCV screening. The current coverage determination only requires Medicare coverage for HCV screening of baby boomers and people at high risk. We are requesting that Medicare should cover screening of everyone between the ages of 18-79, regardless of symptoms or risk group.
Vote “YES” on Louisiana SB 94 so that patients can afford prescription medications
We strongly support Louisiana Senate Bill 94, which would require health insurers to accept and count payments made on behalf of patients for prescription drugs towards their deductible and out-of-pocket maximum. This bill has already passed the Senate is scheduled to be voted on in the House this week. We urge you to support this critical bill for patients.
Vote “YES” on Louisiana SB 94 so that patients can afford prescription medications
We strongly support Senate Bill 94, which would require health insurers to accept and count payments made on behalf of patients for prescription drugs towards their deductible and out-of-pocket maximum. This bill is scheduled to be voted on in the Senate on Monday, May 10th. We urge you to support this critical bill for patients.